Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 31
Titolo Data di pubblicazione Autori Tipo File Abstract
From biology to clinical experience : evolution in the knowledge of neuroendocrine tumours 2009 S. PuscedduF. PietrantonioM. MaccauroE. Verzoni + Article (author) -
Management of advanced genitourinary tumors 2012 Pietrantonio, FilippoBiondani, PamelaVerzoni, Elena + Article (author) -
Targeted therapies and survival: What we can learn from studies in advanced renal cell carcinoma 2013 E. VerzoniF. De Braud + Article (author) -
Patient approach in advanced/metastatic renal cell carcinoma : focus on the elderly population and treatment-related toxicity 2013 E. VerzoniF. de BraudI. Testa + Article (author) -
Prognostic role of pancreatic metastases from renal cell carcinoma : Results from an Italian center 2013 E. VerzoniF. De BraudV. Mazzaferro + Article (author) -
Safety profile and treatment response of everolimus in different solid tumors : an observational study 2014 E. VerzoniS. PuscedduP. BiondaniI. TestaF. Debraud + Article (author) -
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases 2014 E. VerzoniP. BiondaniI. TestaF. de Braud + Article (author) -
First line treatment of metastatic renal cell carcinoma : two standards with different toxicity profile 2014 E. VerzoniF. De Braud + Article (author) -
Treatment of collecting duct carcinoma : current status and future perspectives 2014 I. TestaE. VerzoniF. De Braud + Article (author) -
Targeted treatments in advanced renal cell carcinoma : focus on Axitinib 2014 E. VerzoniI. TestaP. BiondaniF. De Braud + Article (author) -
Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma : results from a large cohort of patients 2014 P. BiondaniE. VerzoniI. TestaF. De Braud + Article (author) -
Study design and clinical evidence in mRCC : can we save axitinib as a first-line therapy? 2014 E. VerzoniF. De Braud + Article (author) -
Butterfly and renal cell cancer : Out of chaos comes order 2014 E. VerzoniF. De Braud + Article (author) -
Rationale and protocol of SOAP : A phase II study to evaluate the efficacy of Sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma 2014 E. VerzoniF. De Braud + Article (author) -
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies : overall results from a large cohort of patients 2015 I. TestaE. VerzoniG. GalliF. De Braud + Article (author) -
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer : a systematic review and meta-analysis 2015 E. VerzoniF. de Braud + Article (author) -
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib 2015 E. VerzoniF. De Braud + Article (author) -
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma : a systematic review and meta-analysis of literature data 2015 E. VerzoniI. TestaF. De Braud + Article (author) -
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 2015 E. VerzoniA. NecchiP. GiannatempoD. RaggiF. De Braud + Article (author) -
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation 2015 D. RaggiP. GiannatempoE. VerzoniF. De BraudA. Necchi + Article (author) -
Mostrati risultati da 1 a 20 di 31
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile